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ORIGINAL ARTICLEEffects ofMedical Interventions onGender Dysphoria
and Body Image: A Follow-Up Study
Tim C. van de Grift, MD,MSc, Els Elaut, PhD, Susanne C. Cerwenka, PhD, Peggy T. Cohen-Kettenis, PhD,
Griet De Cuypere, MD, PhD, Hertha Richter-Appelt, PhD, and Baudewijntje P.C. Kreukels, PhDABSTRACTObjective: The aim of this study from the European Network for the Investigation of Gender Incongruence is to investigate the status of
all individuals who had applied for gender confirming interventions from 2007 to 2009, irrespective of whether they received treat-
ment. The current article describes the study protocol, the effect of medical treatment on gender dysphoria and body image, and the
predictive value of (pre)treatment factors on posttreatment outcomes.
Methods: Data were collected on medical interventions, transition status, gender dysphoria (Utrecht Gender Dysphoria Scale), and body
image (Body Image Scale for transsexuals). In total, 201 people participated in the study (37% of the original cohort).
Results:At follow-up, 29 participants (14%) did not receive medical interventions, 36 hormones only (18%), and 136 hormones and
surgery (68%). Most transwomen had undergone genital surgery, and most transmen chest surgery. Overall, the levels of gender dysphoria
and body dissatisfaction were significantly lower at follow-up compared with clinical entry. Satisfaction with therapy responsive and
unresponsive body characteristics both improved. High dissatisfaction at admission and lower psychological functioning at follow-up
were associated with persistent body dissatisfaction.
Conclusions:Hormone-based interventions and surgery were followed by improvements in body satisfaction. The level of psychological
symptoms and the degree of body satisfaction at baseline were significantly associated with body satisfaction at follow-up.
Key words: body image, gender dysphoria, gender incongruence, hormone therapy, gender confirming surgery.BIS = Body Image Scale, GD = gender dysphoria, GID = Gender
Identity Disorder, GSI = Global Severity Index, SCL = Symptoms
Checklist, UGDS = Utrecht Gender Dysphoria ScaleINTRODUCTION
Body image is a complex multifaceted construct includingphysical characteristics, psychological traits, and societal
norms (1). Body image can be studied through the assessment of
body-related satisfaction, feelings, ideals, and quality of life. In
people with gender dysphoria (GD), body dissatisfaction—
resulting from the discrepancy between “assigned” sex at birth
and experienced gender—often leads to seeking medical care. Ear-
lier research from our group has shown that body dissatisfaction of
people with GD at admission is high and often reaches beyond sex
characteristics only (2,3). Because not all body parts are affected
by treatment, it is uncertain whether medical transition can
completely dissolve body dissatisfaction.
Clinical care for people with GD is mostly conducted in multi-
disciplinary healthcare teams following the Standards of Care (4).
Medical interventions were shown to improve quality of life and
alleviate feelings of GD significantly (5,6). With regard to body
image, both hormonal therapy (7) and genital surgery (8,9) were
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Psychosomatic Medicine, V 79 • 815-823 815of attractiveness and self-confidence (10). Furthermore, individ-
uals with GD who did not receive genital surgery reported higher
levels of body uneasiness (i.e., body-related distress) compared
with people with eating disorders, people with GD postsurgery,
and control participants (11).
In three earlier studies, data from the European Network for the
Investigation of Gender Incongruence (ENIGI) cohort on body
image at clinical admission were analyzed (2,3,12). Before medi-
cal care, participants reported highest dissatisfaction with genitalia
but also with body hair growth (transwomen) and body shape
(transmen) (3). Similar patterns were found when using the Body
Image Scale (BIS) for transsexuals. In addition, body satisfaction
was associated with social transition and with clinicians' valuation
of “passing” (2). The most recent analysis has shown that body
dissatisfaction has a sex-specific composition, in which multiple
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ORIGINAL ARTICLEDespite the increasing attention regarding the body image of
people with GD, few researchers have performed prospective
follow-up studies (13). These studies only reported overall body
satisfaction scores, and none of the studies described body image
in people who experience GD at one point in time but did not re-
ceive medical interventions at follow-up.
Stice and Whitenton (14) performed a large longitudinal study
on the risk factors of body dissatisfaction in adolescent cisgender
girls (2002). Besides body mass index and perceived pressure to
be thin, two major factors associated with body (dis)satisfaction
at follow-up were the degree of psychological symptoms as well
as the level of initial body (dis)satisfaction (14). As mentioned
earlier, previous studies emphasized the importance of medical
transition and social passing as the experienced gender; however,
no prospective study has been performed regarding predictive value
of psychological symptoms and body satisfaction at baseline.
Follow-Up of the European Network for the
Investigation of Gender Incongruence
In the ENIGI initiative, four European gender identity clinics
collaboratively follow a large cohort of people with GD applying
for medical care (15). The main objective of follow-up on the
cohort was to provide a description of the current status of all
applicants after 4 to 6 years after clinical entry and describing
participants with and without medical transition. Relating out-
comes at follow-up to characteristics at clinical entry may help
identify prognostic factors of undergoing, refraining from or
dropping out of the medical trajectory. The present article will
focus on GD and body image specifically.
Aims of the Study
The objective of the current study was to measure the effects of
medical interventions on the level of GD and body satisfaction
6 years after entering a gender identity clinic. A second objec-
tive was to examine whether satisfaction with body characteris-
tics that are or were not targeted directly by medical care has
improved. In addition, the predicting effects of psychological
symptoms and baseline body satisfaction on body satisfaction
at follow-up were studied. Lastly, in the current article, we de-
scribe the study protocol of the ENIGI follow-up study. We ex-
pect the medical interventions to have a positive effect on the
feelings of GD and body satisfaction. In addition, in line with
cisgender studies, we expect that body satisfaction at baseline
and the degree of psychological symptoms also influence body
satisfaction at follow-up.MATERIAL AND METHODS
Participants
A total of 546 people were invited to participate in the study of whom 201
people (37%) both consented and filled out the survey (Amsterdam
n = 100, Ghent n = 61, Hamburg n = 40). Among the study participants
were 135 natal males (119 living in the female role, 12 in the male role,
4 did not report their current gender role) and 66 natal females (60 living
in the male role, 5 in the female role, 1 did not report a current gender role).
Twenty-nine individuals (14%) did not receive any medical interventions at
follow-up, 36 (18%) received hormonal therapy only, and 136 (68%)
received both hormone therapy and surgery.Psychosomatic Medicine, V 79 • 815-823 816Procedure
This study concerns a follow-up survey of the European Initiative for
the Investigation of Gender Incongruence (ENIGI) (15). In the ENIGI
protocol, all people applying for gender confirming medical interventions
in Amsterdam (the Netherlands), Ghent (Belgium), Hamburg (Germany),
and Oslo (Norway) fill out a standard battery of questionnaires during their
diagnostic procedure.
Applicants for medical interventions from Amsterdam, Ghent, and
Hamburg (between 2007 and 2009) of 17 years or older at clinical entry
were invited by their caregivers through mail and/or telephone to fill out
an online survey. All people, regardless of whether they had received
medical interventions or not, were asked to participate. After a month,
all nonresponders received a reminder. Information on the medical proce-
dures received was retrieved from patient records. Ethical approval was re-
ceived by institutional boards in Amsterdam, Ghent, and Hamburg.
Because no ethical approval to contact participants was received in Oslo,
only three clinics participated in the follow-up study.
The survey was provided online through a secured server using
Encrypting File System technology (http://www.unipark.com/en/survey-
software/). After providing consent, respondents received a personalized
link via e-mail from their clinic. Within the survey, participants were routed
automatically to sex- and treatment-specific questions, on the basis of their
answers (e.g., natal females who had transitioned to the male gender would
fill out versions for males). Before the study started, the survey and routing
were tested with several nonparticipating individuals with (previous) GD.
Measures Analyzed in Current Study
During the diagnostic phase at baseline, data were collected on sociodemo-
graphic characteristics, relationships, and gender development (15). The
criteria of the gender identity disorder (GID, currently GD) diagnosis were
scored by the clinician on a self-constructed form, on the basis of the DSM-
IV-TR criteria at the end of the diagnostic phase. At the time of data collec-
tion, this DSM version was still used (16). If both core criteria of GID in
childhood were fulfilled, individuals were categorized as early onset. If
none of the core criteria were fulfilled in childhood, individuals were clas-
sified as late onset (17). People who could not be assigned to either of the
groups (i.e., because they fulfilled only 1 core criterion in childhood), were
considered as a “residual” group. During the diagnostic procedure at the
clinic, the Physical Appearance Scale was filled out by the clinician as well.
This scale scores an observer's appraisal of the masculinity/femininity of a
person's physical appearance on 14 items, rated on a five-point scale,
ranging from very feminine (1) to very masculine (5) (18). The scores
are recoded per natal sex into “least congruent” to “most congruent” with
the experienced gender. Higher scores represent a physical appearance that
is considered less in line with the experienced gender (i.e., the person
“passes” poorly). Any sum score higher than 42 can be regarded as an ap-
pearance more in line with the natal sex than the experienced gender.
Utrecht Gender Dysphoria Scale
The 12-item scale assesses the level of experienced GD. Respondents rate
the level of dysphoria of different dimensions of gender (role) on a one to
five-point Likert scale regarding sex-specific statements. The sum score
ranges from 12 (minimal dysphoria) to 60 (maximal dysphoria) (19,20).
At follow-up, participants received the sex-specific version based on their
current gender role (nontransitioned men and transmen filled out the male
version, and nontransitioned women and transwomen filled out the female
version). Both at baseline and follow-up, the Utrecht Gender Dysphoria
Scale (UGDS) showed better internal consistency in the male version
(αbaseline = 0.84, αfollow-up = 0.76) compared with the female version
(αbaseline = 0.56, αfollow-up = 0.54).
Body Image Scale
This measure consists of 30 items to determine satisfaction with various
body characteristics, rated on a five-point scale of satisfaction, ranging fromSeptember 2017
Medical Treatments, GD, and Body Imagevery satisfied (1) to very dissatisfied (5) (7). The BIS contains equivalent
sex-specific genital body parts to enable comparisons between the natal
sexes. Higher scores represent higher degrees of body dissatisfaction. The
following subscales can be extracted: social and hair items, head and neck
items, muscularity and posture, hip region, chest region, and genitals (12).
Participants of the follow-up study received a modified version including
preoperative genital items (e.g., penis) and postoperative items (e.g.,
neovagina), resulting in 32 items. The BIS showed excellent internal con-
sistency in the present sample (α = 0.90).
Symptom Checklist 90
The Symptom Checklist 90 (SCL-90) is a 90-item survey assessing self-
reported psychological burden on a five-point Likert scale, ranging from
zero (no symptoms) to four (severe symptoms). The Global Severity Index
(GSI) is calculated as the average of all completed items and indicates over-
all experienced psychological symptoms (21). The SCL-90 was distributed
both at baseline and after 6 years and showed excellent internal consistency
(α = 0.98).
Other Measures
At follow-up, background information was collected on sociodemographic
characteristics, social contacts, sexual orientation, and relationships, as well
as on satisfaction with transition and medical treatments. All background
information and information regarding treatment and transition were col-
lected via self-constructed questionnaires. Details on the medical interven-
tions were retrieved from patient records (in Amsterdam and Ghent) or
provided by the responsible psychologist or psychiatrist (in Hamburg).
In addition, well-being, sexuality, psychological functioning, and social
support were assessed but will be reported elsewhere:
Subjective wellbeing: using the Satisfaction With Life Scale (22), the
Subjective Happiness Scale (23), and the Cantril Ladder (24)
Sexuality: measured by means of the Multidimensional Sexuality
Questionnaire (25)
Social support: by means of the Social Support Questionnaire (26).
For an overview of all measures taken at clinical entry, we refer to the
description of the ENIGI initiative, provided by Kreukels et al. (15).
Statistical Analysis
Internal consistency of the provided scales was calculated using Crohnbach
α. Sex differences in demographic characteristics, evaluation of physical
appearance, and frequency of treatments received at follow-up were
assessed by means of χ2 and t tests. The UGDS and SCL-90 scores were
calculated as overall means or sum scores per participant. The means for
the BIS measure were calculated as overall and subscale scores. All out-
come data were normally distributed. Analysis of variance (ANOVA)
repeated measures were used to compare mean BIS and UGDS scores
between admission and follow-up, and one-way ANOVA tests were
performed to assess differences in BIS and UGDS averages among
the three follow-up groups (no treatment, hormones only, and hormones
and surgery). All surgical procedures were compiled into one dichoto-
mous variable to facilitate group comparisons. To assess individual sat-
isfaction with breasts and genitals, surgical procedures for breasts and
genitals were tested separately in addition. The association between
overall GD (UGDS) and body dissatisfaction (BIS) and the correlation
between age and BIS were assessed using Pearson correlations (r). Further-
more, to assess the predictive value of nontreatment factors on body dissat-
isfaction at follow-up, a linear regression was performed including natal
sex, age, Physical Appearance Scale at baseline, social transition at
follow-up, SCL-90 at baseline and follow-up, and BIS at baseline as deter-
minants. Cases were excluded listwise. Effect size was calculated using
Cohen d. Variance and colinearity were assessed (−0.4 < r < 0.4), and
homoscedasticy, linearity of residuals, and errors were judged through
(P–P) plots and histograms. All analyses were performed using SPSS for
Windows 22.0 (SPSS Inc, Chicago, Ill).Psychosomatic Medicine, V 79 • 815-823 817RESULTS
The characteristics of the study sample are displayed in Table 1.
Compared with the natal females, natal male respondents were sig-
nificantly older at admission and their physical appearance was
evaluated less congruent with their experienced gender by the cli-
nician. The natal female group consisted mostly of individuals
with early onset of gender dysphoric feelings. In both at admission
and follow-up, most of the respondents experienced low levels of
psychological symptoms. In comparison with the eligible but non-
participating individuals, the study participants were significantly
older (36.4 [SD = 12.9] versus 31.9 [SD = 11.3] years old;
t(540) = 4.27, p < .001) and more educated (33.8% versus 18.8%
received high education at baseline; χ2(2) = 20.2, p <.001).
Participants reported significantly higher baseline BIS scores
(M = 3.33 [0.54]), compared with individuals who did not partic-
ipate (M = 3.19 [0.61]; t(516) = 2.58, p = .01), which implies
stronger body dissatisfaction among the study participants. The
groups did not differ significantly in terms of fulfillment of the
GID diagnosis.Medical Interventions
Ninety-one percent of the natal female (which includes mostly
transmen) respondents had received cross-sex hormone therapy
at follow-up, compared with 83% of the natal males (mostly
transwomen). Most natal male participants had undergone epila-
tion (86%) at follow-up. Surgical interventions, as a percentage
of natal sex, are displayed in Table 1. There were no significant dif-
ferences between the natal sexes regarding the average duration of
hormone therapy or follow-up since surgery.Gender Dysphoria
The average sum scores of GD were the following:
UGDSadmission = 53.1 (SD = 6.7), UGDSno intervention = 20.2
(SD = 12.8), UGDShormones = 20.1 (SD = 8.8), and UGDShormones
& surgery = 15.5 (SD = 4.3). The scores were significantly lower in
all of the follow-up groups when compared with clinical admis-
sion, showing a decrease in GD (Fig. 1A). Within the follow-up
groups, people who received both hormone therapy and surgery
reported significantly less feelings of GD when compared with
people without medical interventions. Such a difference was
not found between the “hormones only” and “no intervention”
groups. The baseline UGDS score of the “no interventions” group
was significantly lower (Mno interventions [SD] = 48.4 [9.1]) than the
other groups (Mhormones [SD] = 52.0 [5.4], Mhormones & surgery
[SD] = 54.3 [5.8]; F(2,193) = 10.58, p < .001). Twenty-eight
people did not fill out the UGDS (of whom 20 in the no
interventions group), in some cases because participants ended the
survey before finishing all instruments. In the no intervention
group, all people who did not socially transition had missing data,
which was the result of a programming error in the survey routing.Body Image
Overall Body Satisfaction
Comparable with UGDS scores, respondents reported significantly
higher overall body dissatisfaction at admission (BISadmission = 3.34
[SD = 0.52]) when compared with follow-up (Fig. 1B). AtSeptember 2017
TABLE 1. Sample Characteristics
Assigned Male at Birth
(n = 135)
Assigned Female at Birth
(n = 66) Test Statistics
Age, M (SD), y* 39.2 (12.8) 30.6 (11.3) t(195) = 4.55, p < .001
Education, n (%)*
Low 13 (10) 8 (12) p = .62
Intermediate 56 (42) 31 (47)
High 64 (48) 27 (41)
GID diagnosis, n (%)* χ2(3) = 34.85, p < .001
No 12 (11) 2 (3)
Early onset 35 (32) 46 (79)
Late onset 45 (41) 7 (12)
Residual 19 (17) 3 (5)
SCL-90, GSI, M (SD)
Baseline 0.50 (.42) 0.60 (.55) p = .16
Follow-up 0.48 (.50) 0.57 (.57) p = .27
Physical Appearance Scale, M (SD)* 44.10 (9.74) 40.02 (6.75) t(155) = 2.73, p = .007
Medical interventions, n (%)†
Hormone therapy 110 (83) 59 (91) p = .10
Epilation 80 (86)
Vaginoplasty 79 (61)
Mamma augmentation 38 (30)
Adam's apple reduction 9 (8)
Facial feminization surgery 8 (6)
Mastectomy 53 (79)
Oophorectomy/hysterectomy 52 (78)
Penis construction 18 (27)
Years since medical intervention, M (SD)†
Hormone therapy 4.6 (2.3) 4.9 (1.6) p = .39
Last surgery 2.4 (1.4) 2.6 (1.4) p = .50
M (SD) = mean (standard deviation); GID = Gender Identity Disorder (DSM-IV-TR), SCL = Symptom Checklist; GSI = Global Severity Index.
Because of missing data, numbers may sum up to less than 201.
*Information obtained at baseline.
†Information obtained at follow-up.
ORIGINAL ARTICLEfollow-up, peoplewithoutmedical interventions (BISno intervention = 3.24
[SD = 0.64]) were significantly more dissatisfied with their body
than the people who did receive hormone therapy with(out) sur-
gery (BIShormones = 2.72 [SD = 0.73], BIShormones & surgery = 2.51
[SD = 0.58]). Overall body dissatisfaction and GD were not
found to be significantly correlated, neither at baseline nor at
follow-up, implying that the degree of overall body (dis)satisfac-
tion did not necessarily relate to the degree of GD. At baseline,
however, the level of GD was moderately positively correlated
to the level of genital dissatisfaction (r(183) = 0.39, p < .001). This
association was not found at follow-up (r = 0.05).
Body Area Satisfaction
The average overall and subscale scores of body satisfaction
at admission and follow-up are displayed in Figure 2. On av-
erage, the respondents who did not receive medical interven-
tions at follow-up had similar levels of body dissatisfaction
at baseline and at follow-up. People who did receive hormonePsychosomatic Medicine, V 79 • 815-823 818therapy with or without surgery reported lower body dissatisfac-
tion compared with baseline levels. Dissatisfaction with genitals
and breasts was highest in the no intervention group at follow-up.
Within the groups who underwent medical interventions,
satisfaction with both therapy responsive and nonresponsive
body characteristics improved, when compared with clinical
entry. At follow-up, people who have gone through medical in-
terventions reported body satisfaction generally between two
(satisfied) and three (neutral). No significant differences on
most of the BIS subscales were found between respondents
who had received hormones only and the respondents who also
received surgery. The exception to this was genital dissatisfac-
tion, which was significantly lower in the group that had sur-
gery (M = 2.36 [SD = 1.21]), compared with the hormones
only group (M = 3.36 [SD = 1.43]; t(160) = 4.13, p < .001).
In transwomen, satisfaction with breasts was higher in the
group who received breast enlargement (M = 1.90 [SD= .72])
in comparison with the group who received other surgeries thanSeptember 2017
FIGURE 1. A, GD at clinical entry and follow-up displayed per treatments received. UGDS = Utrecht Gender Dysphoria Scale (12 = least
dysphoric, 60 =most dysphoric). Baseline and follow-up levels of GD are displayed for the groups without and with hormonal and surgical
therapy at follow-up; hormone therapy is mostly cross-sex hormones, surgery includes facial, chest, and/or genital surgery; the displayed n
values report the available data per measure; SDno intervention admission = 9.2, SDno intervention follow-up = 12.8, SDhormone therapy admission = 5.4,
SDhormone therapy follow-up = 8.8, SDsurgery admission = 5.8, SDsurgery follow-up = 4.3. *Due to a programming error, the follow-up UGDS data
were available of nine participants only. B, Body dissatisfaction at clinical entry and follow-up displayed per treatments received. BIS =
body image scale (1 = very satisfied, 5 = very dissatisfied). Baseline and follow-up levels of body dissatisfaction are displayed for the
groups without and with hormonal and surgical therapy at follow-up; the displayed n values report the available data per measure;
hormone therapy is mostly cross-sex hormones, surgery includes facial, chest, and/or genital surgery; SDno intervention admission = 0.59,
SDno intervention follow-up = 0.64, SDhormone therapy admission = 0.61, SDhormone therapy follow-up = 0.73, SDsurgery admission = 0.51, SDsurgery
follow-up = 0.58. Baseline versus follow-up; UGDS: F(1,168) = 13,668.37, p < .001; BIS: F(1,183) = 202.85, p < .001. Among follow-up
groups; UGDS: F(2,170) = 9.54, p < .001; BIS: F(2,187) = 14.02, p < .001. GD = gender dysphoria; SD = standard deviation.
Medical Treatments, GD, and Body Imagebreast enlargement (M = 2.48 [SD = 1.00]), as well as people on
hormones only (M = 2.70 [SD = 1.10]; F(2,105) = 4.89, p = .009).
Within the “hormones only” group, different scores were observed
between the people who planned (n = 14) and did not plan (n = 21)
to undergo genital surgery in the future with regard to overall body
satisfaction (Mplanned [SD] = 3.29 [0.61], Mnot planned [SD] = 2.35
[0.54]; t(33) = 4.75, p < .001) as well as for genital body satisfactionFIGURE 2. Dissatisfaction with body areas of all participants (at basel
Scale (1 = very satisfied, 5 = very dissatisfied). Baseline and follow-up l
baseline (“admission”) and differentiated for the groups without and w
values report the available data per measure; SDadmission all = 0.54,
SDadmission muscularity and posture = 0.68, SDadmission hips = 0.76, SDa
all = 0.64, SDno intervention social and hair = 0.64, SDno intervention head a
intervention hips = 0.77, SDno intervention breasts = 1.1, SDno intervention gen
SDhormones head and neck = 1.0, SDhormones muscularity and posture = 0.
genitals = 1.0; SDsurgery all = 0.58, SDsurgery social and hair = 0.74, SDsurgery
hips = 0.75, SDsurgery breasts = 0.95, SDsurgery genitals = 1.2. SD = standar
Psychosomatic Medicine, V 79 • 815-823 819(Mplanned = 4.76 [SD = 0.40], Mnot planned [SD] = 2.42 [1.03];
t(33) = 8.07, p < .001).
Nontreatment Predictors of Body Satisfaction
To assess the effects of nontreatment factors—both general and
psychological—on body (dis)satisfaction at follow-up, a linear re-
gression was performed (Table 2). The model assumptions wereine) and per treatments received (at follow-up). BIS = Body Image
evels of body area dissatisfaction are displayed of all participants at
ith hormonal and surgical therapy at follow-up; The displayed n
SDadmission social and hair = 0.72, SDadmission head and neck = 0.71,
dmission breasts = 0.82, SDadmission genitals = 0.72; SDno intervention
nd neck = 0.82, SDno intervention muscularity and posture = 0.77, SDno
itals = 1.1; SDhormones all = 0.73, SDhormones social and hair = 0.77,
76, SDhormones hips = 0.80, SDhormones breasts = 1.2, SDhormones
head and neck = 0.73, SDsurgery muscularity and posture = 0.65, SDsurgery
d deviation.
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TABLE 2. Linear Regression Model of Body Dissatisfaction
at Follow-Up
Predictor β Test Statistics
General factors
Sex assigned at birth* −0.02 p = .83
Age* 0.10 p = .23
Passing (Physical Appearance Scale)* 0.05 p = .50
Social transition† 0.01 p = .89
Psychological factors
Psychological functioning (SCL-90, GSI)* 0.03 p = .71
Psychological functioning (SCL-90, GSI)† 0.31 t = 3.78, p < .001
Body dissatisfaction (BIS overall mean)* 0.32 t = 4.27, p < .001
SCL = Symptom Checklist; GSI = Global Severity Index; BIS = Body Image Scale.
Model statistics: R2 = .267; F(7,139) = 7.23; p < .001 (ANOVA).
*Information obtained at clinical admission.
†Information obtained at follow-up.
ORIGINAL ARTICLEmet (see the notes hereinafter the table). None of the general
characteristics were found to be of predictive value, including
natal sex, age, physical passing at admission, and social transition
status at follow-up. Body dissatisfaction at admission was a
significant predictor of body dissatisfaction at follow-up. This
implies that a higher degree of overall body dissatisfaction before
medical interventions predicts a higher degree of (persisting) body
dissatisfaction after medical interventions. Moreover, psychological
symptoms at follow-up (SCL-90 GSI score) were associated with
body dissatisfaction at follow-up, which means that people with
more psychological symptoms at follow-up were more dissatisfied
with their bodies after medical interventions. Body dissatisfaction at
follow-up was not predicted by psychological symptoms at baseline.FIGURE 3. Social (de)transition of respondents without medical in
transitioned to another gender role, of whom some had transitioned ba
Psychosomatic Medicine, V 79 • 815-823 820Respondents Without Medical Intervention
Twenty-nine respondents had not received medical interventions
at follow-up, of whom 23 natal males and six natal females. Some
of them (5 natal males and 4 natal females) reported that this was
their voluntary choice, whereas others mentioned different rea-
sons. Among the motivations not to receive medical care were
anxiety (n = 4: 3 natal males and 1 natal female), social circum-
stances (e.g., children; n = 3: all natal males), postponing the deci-
sion (n = 2: both natal females), benefit from psychological
counseling (n = 1: natal female), and high age (n = 1: natal male).
More than 60% of the nonmedically treated group, regardless
of the clinic, received psychological counseling, mostly outside
of the participating clinics. Twelve participants dropped out the di-
agnostic procedure before a diagnosis could be made. Among the
others, seven participants without medical interventions fulfilled
the GID criteria according to their clinician, one was diagnosed
with fetishistic transvestism, one with GID not otherwise speci-
fied, and for one participant data on the diagnosis were missing.
Figure 3 displays the social (de)transitioning of the people without
medical interventions. Five respondents did not provide informa-
tion on their current gender role. On the question whether the re-
spondent was planning to (re)apply for medical interventions in
the future, most people said no (n = 9) or were unsure (n = 8),
six people were planning to apply for medical care, and the other
six did not respond to this question. There was no significant dif-
ference in the percentage of respondents without medical interven-
tions between the three clinics.DISCUSSION
When compared with clinical entry, experienced GD and body
dissatisfaction were lower in follow-up groups with and without
medical interventions. People who received both hormone therapy
and surgery hadmore favorable body satisfaction scores comparedterventions. At/after clinical admission, some participants (had)
ck to the role of their gender assigned at birth at follow-up.
September 2017
Medical Treatments, GD, and Body Imagewith the people who used hormones only, both on therapy respon-
sive and therapy unresponsive body characteristics. Genital satis-
faction was particularly higher in the group who received
surgery. In addition to the medical interventions, body dissatisfac-
tion at baseline as well as psychological symptoms at follow-up
was found to be associated with body dissatisfaction at follow-up.
Earlier studies have shown that medical transition alleviates
most of the experienced GD in (young) adults (5,27,28). The base-
line UGDS level in the current study (53.5) was similar to the
levels reported in these studies, sowere the postintervention levels,
which were comparable with cisgender individuals (5,28). This
decrease shows the effectiveness of medical interventions and so-
cial transition. Remarkably, feelings of GDof people without med-
ical interventions also lowered. However, only seven of this group
were thought to fulfill the GID criteria, whereas the others did not
or dropped out of the diagnostic procedure before this could be
assessed. At baseline, this group already showed lower UGDS
scores indicating less severe GD. In addition, because of a pro-
gramming error, in the “no interventions” group, only people
who had socially transitioned received the UGDS. Living in the
social role of the experienced gender may have decreased the level
of GD already. Other explanations may be the positive effects of
psychological counseling or prospect of future medical interven-
tions, or people may have found alternative ways of living with
their gender incongruence.
Follow-up studies on body image of people with GD are scarce
(13). Smith et al. (5) and de Vries et al. (28) administered the BIS
instrument before and after the start of medical transition (5,28).
We found that people who were postoperative reported similar
rates of body satisfaction compared with the earlier reported rates
after surgery. Medical transition may increase body satisfaction
and psychological wellbeing by improving the masculinity or fem-
ininity of body characteristics (e.g., voice deepening after testos-
terone or surgical creation of a vagina), making the body more
congruent with the experienced gender identity, which positively
influences the evaluation of the particular body characteristic and
alleviates the level of GD. In addition, the altered bodymay be eas-
ier to “pass,” leading to more supportive social experiences. We
have observed the influence of social passing on body satisfaction
before (2). de Vries et al. (28), however, reported that body satis-
faction with neutral characteristics (not primary or secondary)
did not improve significantly after medical transition, possibly be-
cause all participants in that study had been on puberty blocking
and were already relatively satisfied with these body parts. The
present data show the biggest difference in body satisfaction be-
tween the groups with and without hormone therapy, although
genital satisfaction was significantly higher in the group with sur-
gery. In the follow-up group without medical interventions, the
level of body dissatisfaction did not decrease as much as the level
of GD. This may indicate that despite the lowered feelings of GD,
there is still some body dissatisfaction (e.g., because someone
socially transitioned without medical interventions). There is
increasing discussion in the fields of psychosomatic and behav-
ioral medicine about differences between biological sex versus
gender roles in predicting disease risk factors and treatment out-
comes (29,30). Although hormone and surgical treatments
showed to improve psychological measures in our population,
gender roles (29) and sexual orientation (31) have beenPsychosomatic Medicine, V 79 • 815-823 821described to directly affect mental health as well. In addition,
the hormonal and surgical interventions in our participants
may also be associated with consequences for medical out-
comes such as cardiovascular diseases, although absolute risk
increase was found to be low (32). The effects of medical inter-
ventions on outcomes and disease risk and their interaction with
gender and sex deserve attention in future studies (30). None of
the general characteristics significantly predicted overall body
(dis)satisfaction at follow-up. Earlier studies found that body dis-
satisfaction at baseline was significantly higher in transwomen
compared with transmen (2). This difference disappears after
medical treatment or the study was underpowered to detect a dif-
ference (a small effect of sex was observed: d = 0.16). The same
may be the case for the influence of age (a very weak correlation
of r = 0.09 was found); previous research found that older transmen
were less dissatisfied with their body, compared with their younger
counterparts (33).
Psychological symptoms at follow-up were associated with
body dissatisfaction at follow-up, which was found in earlier re-
search (5,33). Lower body satisfaction may result from a lower
overall satisfaction with life but can also be the consequence of a
response bias in which both instruments were filled out negatively.
Body dissatisfaction at baseline was another significant predictor
of body dissatisfaction at follow-up, a finding that is in line with
the results of Smith et al. (5) and studies in cisgender people
(14). This suggests that people with a more severe body dissatis-
faction are more likely to experience continued body dissatisfac-
tion after medical transition. Nevertheless, a reverse relationship
cannot be excluded (people with lower body satisfaction may
“pass” less, experience more social difficulties and consequently
more psychological symptoms). High treatment expectations can
influence postoperative satisfaction as well; however, no data with
regard to this topic were collected at baseline.
In contrast to other follow-up studies, the present study in-
cluded all clinical applicants, irrespective of whether they decided
to undergo medical treatment or not. However, at follow-up, most
respondents had received hormone therapy with or without
surgery, and only 29 participants received neither. The latter
group reported different motives for not having gone through
medical transition despite approaching a clinical facility, in-
cluding their own choice, anxiety, social circumstances, and
benefit from psychological counseling. At follow-up, most
of them lived (again) in the social role of their natal sex. Pre-
vious studies reported “no intervention” rates of 22% and 32%
at follow-up (5,34,35). Reasons included not being referred
(yet) by the clinician, the severity of GD feelings, and psycho-
logical problems (5). The latter findings were confirmed in the
current study: UGDS at baseline was lower in people without
medical interventions, and one of the reported reasons among
motivations not to undergo medical care was anxiety. Both
lower levels of GD and anxiety can reduce the motivation to
pursue obtaining medical treatments or prioritize alternative
care (e.g., psychological counseling).Limitations
The first limitation of the current study is that the Body Image
Scale only measured body satisfaction as indicator of body image,
leaving influential cognitions, feelings, and behavior out of scope.September 2017
ORIGINAL ARTICLEFurthermore, outcome measurement using sex-specific instru-
ments is generally complicated when study participants medically
transition. Because the UGDS instrument was initially not devel-
oped to make such intrapersonal cross-sex comparisons, state-
ments on pre-post differences should be read prudently. Other
methodological limitations include the fact that the compared
groups were not matched, and therefore, other factors may have in-
fluenced the observed outcomes. The missing data on some mea-
sures may have had a similar effect. Group comparisons have
been limited by the small sample size of the no intervention group,
compared with the treated group. Some of the observed effect of
medical treatments on the outcome variables may have been
caused by regression to the mean in the different groups. In addi-
tion, physical outcome of medical transition is limited to a self-
report measure only. In addition, because of the composition of
the studied group and the response rate of 37%, insights on the
body image of people with GD may be limitedly generalizable.
The present study only describes the study responders, a group that
was more educated than the nonresponders. Differences in body
satisfaction may be possible between responding and
nonresponding people. Because of a technical error, no conclu-
sions can be drawn on the level of GD of people who neither re-
ceived medical interventions nor socially transitioned.CONCLUSIONS
The current study is the first comprehensive study to follow up on
a larger group of people with GD applying for medical care in
three gender identity clinics in Europe, regardless of the followed
medical treatments. Medical care effectively reduced feelings of
GD and improved body satisfaction. Hormone therapy decreased
overall body dissatisfaction, whereas surgery contributed mostly
to genital satisfaction. Analysis of predictors of persisting body
dissatisfaction indicated that psychological mechanisms, next to
medical interventions, contributed to body satisfaction. The con-
cept of body image may assist clinicians and individuals with
GD to develop treatment plans, which optimally improve psycho-
logical well-being. Especially, people with more profound and
more overall body dissatisfaction could benefit from receiving ad-
ditional counseling on this subject. Because current data suggest
that a complete medical transition cannot dissolve all body dissat-
isfaction in some, psychotherapy may additionally offer guidance
to accept the less than perfect body (aspects).
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